Clopidogrel Prices, Demand, News, Chart and Forecast
Clopidogrel Prices In Korea
- Korea: $43,000/Ton
In the first quarter of 2024, the price of the clopidogrel in in Korea reached $43,000/Ton. Similarly, in Chile, the clopidogrel prices hit $58,000/Ton.
The latest report by IMARC Group, titled "Clopidogrel Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data," provides a thorough examination of the Clopidogrel Prices . This report delves into the price of Clopidogrel globally, presenting a detailed analysis, along with informative Price Chart. Through comprehensive Price analysis, the report sheds light on the key factors influencing these trend. Additionally, it includes historical data to offer context and depth to the current pricing landscape. The report also explores the Demand, analyzing how it impacts Industry dynamics. To aid in strategic planning, the price forecast section provides insights into price forecast, making this report an invaluable resource for industry stakeholders.
Clopidogrel Prices Analysis
- Chile: $58,000/Ton
Report Offering:
- Monthly Updates - Annual Subscription
- Quarterly Updates - Annual Subscription
- Biannually Updates - Annual Subscription
The study delves into the factors affecting Clopidogrel price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.
The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.
Request For a Sample Copy of the Report: https://www.imarcgroup.com/clopidogrel-pricing-report/requestsample
Clopidogrel Price Trend- Last Quarter
Clopidogrel is an antiplatelet medication commonly prescribed to prevent blood clots in patients with cardiovascular conditions such as heart attacks, strokes, and peripheral artery disease. It works by inhibiting platelets from clumping together, thereby reducing the risk of clot formation in the arteries. Available in various formulations, Clopidogrel is widely used globally due to its effectiveness and the increasing prevalence of cardiovascular diseases. The global Clopidogrel market is driven by several key factors, including the rising incidence of cardiovascular diseases and the aging population, which increases the demand for effective antiplatelet therapies.
The market is also influenced by the expanding generic drug segment, making Clopidogrel more accessible and affordable, particularly in emerging markets. Technological advancements in pharmaceutical manufacturing and distribution, along with increasing awareness about cardiovascular health, further contribute to market growth. Trends such as strategic partnerships and collaborations among pharmaceutical companies to enhance research, development, and distribution capabilities are shaping the competitive landscape. Additionally, regulatory support for generic drug approval processes is expected to bolster market expansion in the coming years.
Clopidogrel Industry Analysis
In the fourth quarter of 2023, clopidogrel API prices in North America mirrored those in the APAC region, showing an upward trend due to increased downstream consumption. Early in the quarter, prices dipped slightly due to weakened purchasing sentiments and low new inquiries. However, by November 2023, prices stabilized and increased, driven by stronger purchasing sentiments and sufficient inventory. The challenges in global shipping, particularly near the Suez and Panama Canals, further impacted transportation costs, influencing the pricing of clopidogrel.
The Asia Pacific market for clopidogrel saw a slight decline in prices in October 2023, influenced by cautious inquiries and lower feedstock prices. However, by November, prices rose due to increased demand for clopidogrel-based medications, especially during India's winter season, which heightened cardiovascular health concerns. The December market was marked by increased freight costs and currency depreciation, creating a complex pricing environment as overseas traders capitalized on lower rates to procure goods more favorably.
In Europe, clopidogrel prices followed a pattern similar to North America, with a drop in October 2023 due to ample domestic supply and cautious buying in the pharmaceutical sector. By mid-quarter, prices rebounded as consumer sentiment improved, leading to increased bidding and order placements. As Germany, a key importer, aligned with major exporting nations, the prices continued to rise through December, reflecting global market trends and restocking efforts during a period of steady demand growth.
Regional Price Analysis:
- Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand
- Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
- North America: United States and Canada
- Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
- Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco
Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian